The University of Cambridge is joining with Microsoft to help tackle the problem of ‘brain drain’ in AI and machine learning research.
The University of Cambridge is a partner in the €1 billion Quantum Flagship, an EU-funded initiative to develop quantum technologies across Europe.
Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
Researchers from the Cambridge Graphene Centre, together with industrial and academic collaborators within the European Graphene Flagship project, showed that integrated graphene-based photonic devices offer a solution for the next generation of optical communications.
Researchers have used a combination of location and transport data to predict the likelihood that a given retail business will succeed or fail.
Three Cambridge researchers are among the new Fellows announced today by the Royal Academy of Engineering, in recognition of their outstanding contributions.
A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.
Researchers have successfully demonstrated how an electronic device implanted directly into the brain can detect, stop and even prevent epileptic seizures.